David C Hastings Arbutus Biopharma Corp (ABUS) insider trading activity

ABUS Quotes by TradingView

David C Hastings is Chief Financial Officer of Arbutus Biopharma Corp. Currently has a direct ownership of 249,824 shares of ABUS, which is worth approximately $826,917. The most recent transaction as insider was on Feb 14, 2025, when has been sold 90,100 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 250K
37.34% 3M change
37.34% 12M change
Total Value Held $826,917

DAVID C HASTINGS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2025
BUY
Grant, award, or other acquisition
-
90,100 Added 26.51%
249,824 Common Shares
Feb 04 2025
SELL
Open market or private sale
$72,760 $3.28 p/Share
22,183 Reduced 12.19%
159,724 Common Shares
Feb 02 2024
SELL
Open market or private sale
$22,159 $2.31 p/Share
9,593 Reduced 5.01%
181,907 Common Shares
Feb 01 2024
BUY
Grant, award, or other acquisition
-
112,500 Added 37.01%
191,500 Common Shares
Feb 01 2023
BUY
Grant, award, or other acquisition
-
79,000 Added 50.0%
79,000 Common Shares

Also insider at

ETTX
Entasis Therapeutics Holdings Inc. Healthcare
Director
SCYX
SCYNEXIS INC Healthcare
DCH

David C Hastings

Chief Financial Officer
Waltham, MA

Track Institutional and Insider Activities on ABUS

Follow Arbutus Biopharma Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABUS shares.

Notify only if

Insider Trading

Get notified when an Arbutus Biopharma Corp insider buys or sells ABUS shares.

Notify only if

News

Receive news related to Arbutus Biopharma Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABUS